{"id":"W4210418169","doi":"10.54194/digr6414","title":"Pharmacy scope of practice and access to Opioid Agonist Therapies (OAT) in Canada after COVID-19","year":2022,"lang":"en","type":"article","venue":"Canadian Health Policy","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Indivior","keywords":"Pharmacy; Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Scope (computer science); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Agonist; Medicine; Opioid epidemic; Opioid; Pharmacy practice; Buprenorphine; Pharmacology; Family medicine; Virology; Internal medicine; Receptor; Computer science; Disease; Infectious disease (medical specialty)","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003254591,0.0004011872,0.0006613377,0.003130818,0.006287002,0.006988332,0.002326193,0.004308348,0.008601491],"category_scores_gemma":[0.0219696,0.0006346926,0.001342423,0.006949009,0.001720744,0.001828138,0.001436016,0.005579507,0.0005393033],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.2109589,"about_ca_system_score_gemma":0.374017,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9975405,"about_ca_topic_score_gemma":0.9990337,"domain_scores_codex":[0.9929408,0.0002124956,0.0003261578,0.0003496851,0.003936672,0.002234225],"domain_scores_gemma":[0.9647861,0.001935318,0.001992591,0.0002535819,0.01887544,0.01215698],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.0002357247,0.000164869,0.07786815,0.0003843437,0.0001233596,0.0003021048,0.001400643,0.0004126447,0.0001132036,0.0120719,0.8562858,0.05063725],"study_design_scores_gemma":[0.0002752073,0.00008034799,0.5535477,0.002496412,0.0002029109,0.0002212578,0.004996962,0.000920435,0.0002793164,0.001261304,0.435537,0.0001811969],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.07134309,0.06437789,0.0002474202,0.749224,0.01618717,0.0002876731,0.02338847,0.0001111371,0.07483321],"genre_scores_gemma":[0.6011358,0.07612271,0.001281454,0.170499,0.01060587,0.0003415931,0.01252782,0.0001891313,0.1272966],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.789041,"threshold_uncertainty_score":0.9151758,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03968635140387691,"score_gpt":0.4128316845416423,"score_spread":0.3731453331377654,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}